Gene expression profiling (GEP) for the prediction of response to neoadjuvant paclitaxel and gemcitabine in breast cancer (BC). Preliminary results from a Phase II trial
Llombart-Cussac, A., Moreno-Bueno, G., Ruiz, A., Albanell, J., Mayordomo, J. I., Carñana, V., Guillem, V., Diaz-Uriarte, R., Palacios, J., Garcia-Ribas, I.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Gene expression profiling (GEP) for the prediction of response to neoadjuvant paclitaxel and gemcitabine in breast cancer (BC). Preliminary results from a Phase II trial
Llombart-Cussac, A., Moreno-Bueno, G., Ruiz, A., Albanell, J., Mayordomo, J. I., Carñana, V., Guillem, V., Diaz-Uriarte, R., Palacios, J., Garcia-Ribas, I.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article